COVID-19 in Relation to Polypharmacy and Immunization (2020–2024)
Patients > 70 years who receive ≥5 nT, without prior COVID-19 infections, should be the priority for prevention, with updated vaccination and early treatments to reduce hospitalizations.
Authors
- Celia Lozano-Paz (ORCID: https://orcid.org/0000-0003-2301-2509)
- Josep Vidal‐Alaball (ORCID: https://orcid.org/0000-0002-3527-4242)
- Roger Valls-Foix (ORCID: https://orcid.org/0000-0002-1016-4039)
- Marta Juanes-González (ORCID: https://orcid.org/0000-0002-8682-6000)
- Anna Puigdellívol‐Sánchez (ORCID: https://orcid.org/0000-0001-7239-2953)
- Ana Calderón-Valdiviezo
- Marta González-Salvador (ORCID: https://orcid.org/0009-0009-9012-2899)
Institutions
- Consorci Sanitari de Terrassa (ES)
- Institut Català de la Salut (ES)
- Universitat de Barcelona (ES)
Publication Details
- Journal
- Viruses
- Published
- 2024-09-27
- DOI
- https://doi.org/10.3390/v16101533
- Citations
- 3
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 1.17